Efficacy and safety of liposome-encapsulated 4-n-butylresorcinol 0.1% cream for the treatment of melasma: a randomized controlled split-face trial.

Source:http://linkedlifedata.com/resource/pubmed/id/20507399

Download in:

View as

General Info

PMID
20507399